Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab
Clinical trial NCT02935790 · COMPLETED
Trial details
- NCT number
- NCT02935790
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-30
- Primary completion
- 2017-04-07
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.